Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

May 31, 2006

Conditions
Gastric Cancer
Interventions
DRUG

S-1

DRUG

cisplatin

Trial Locations (11)

19104

Abramson Cancer Center at the University of Pennsylvania, Philadelphia

60611

Northwestern University Robert H Lurie Comprehensive Cancer Center, Chicago

60637

University of Chicago, Chicago

77030

MD Anderson Cancer Center, Houston

87108

Lovelace Sandia Health System, Albuquerque

New Mexico VA Health Care System, Albuquerque

87131

University of New Mexico - Albuquerque, Albuquerque

90025

Rosen, Lee, Los Angeles

90089

University of Southern California Norris Comprehensive Cancer Center, Los Angeles

96817

Chong, Clayton, Honolulu

Straub Clinic and Hospital, Honolulu

All Listed Sponsors
lead

Taiho Oncology, Inc.

INDUSTRY

NCT00072787 - Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter